Showing 1 - 11 results of 11 for search '"main risk factors"', 查詢時間: 0.02s Refine Results
  1. 1
    Multivariate analysis between DENV and CHIKV seroconversion and selected risk factors.

    Multivariate analysis between DENV and CHIKV seroconversion and selected risk factors. 由 Bethel Alebel Bayrau (22676588)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  2. 2
    Seroprevalence of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022.

    Seroprevalence of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022. 由 Bethel Alebel Bayrau (22676588)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  3. 3
    Descriptive statistics and demographics of study participants, Ukunda and Kisumu sites, Kenya, Dec 2019–Feb 2022.

    Descriptive statistics and demographics of study participants, Ukunda and Kisumu sites, Kenya, Dec 2019–Feb 2022. 由 Bethel Alebel Bayrau (22676588)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  4. 4
    DENV and CHIKV IgG serology and RT-PCR test results among overall study population and individual study sites Ukunda and Kisumu, Kenya, Dec 2019–Feb 2022.

    DENV and CHIKV IgG serology and RT-PCR test results among overall study population and individual study sites Ukunda and Kisumu, Kenya, Dec 2019–Feb 2022. 由 Bethel Alebel Bayrau (22676588)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  5. 5
    Univariate analysis between DENV and CHIKV seropositivity and selected risk factors.

    Univariate analysis between DENV and CHIKV seropositivity and selected risk factors. 由 Bethel Alebel Bayrau (22676588)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  6. 6
    Seroconversion of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022.

    Seroconversion of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022. 由 Bethel Alebel Bayrau (22676588)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  7. 7
    Kaplan Meier survival curves for new CHIKV seropositivity during the 2- year study period from Dec 2019 – Feb 2022.

    Kaplan Meier survival curves for new CHIKV seropositivity during the 2- year study period from Dec 2019 – Feb 2022. 由 Bethel Alebel Bayrau (22676588)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  8. 8
    Kaplan Meier survival curves for new DENV seropositivity during the 2-year study period from Dec 2019 – Feb 2022..

    Kaplan Meier survival curves for new DENV seropositivity during the 2-year study period from Dec 2019 – Feb 2022.. 由 Bethel Alebel Bayrau (22676588)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  9. 9
    Multivariate analysis between DENV and CHIKV seropositivity and selected risk factors.

    Multivariate analysis between DENV and CHIKV seropositivity and selected risk factors. 由 Bethel Alebel Bayrau (22676588)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  10. 10
    Univariate analysis between DENV and CHIKV seroconversion and selected risk factors.

    Univariate analysis between DENV and CHIKV seroconversion and selected risk factors. 由 Bethel Alebel Bayrau (22676588)

    出版 2025
    主題:
    加到收藏夾
    Saved in:
  11. 11
    Distribution of DENV and CHIKV seroprevalence by age group of participants in the study.

    Distribution of DENV and CHIKV seroprevalence by age group of participants in the study. 由 Bethel Alebel Bayrau (22676588)

    出版 2025
    主題:
    加到收藏夾
    Saved in:

檢索工具: